The ACR and SBI took issue with a recent study on the long-term mental anguish caused by false-positives from mammograms.
A recent study reporting the long-term mental anguish in women who obtain false-positives from mammograms should be taken with a grain of salt, say the American College of Radiology (ACR) and the Society of Breast Imaging (SBR). The study findings, published earlier this month in the Annals of Family Medicine, stated that false-positive findings on screening mammography cause long-term harm.
Researchers from Denmark surveyed 454 women who had received abnormal mammography findings following screening over one year. Researchers recruited two women with normal results for each woman who had abnormal results, all from the same day and same clinic. The women completed a validated questionnaire, the Consequences of Screening in Breast Cancer, at baseline, one, six, 18, and 36 months. The questionnaire covers 12 psychosocial outcomes.
The researchers found that six months after the final diagnosis, women who received false-positive findings reported “changes in existential values and inner calmness as great as those reported by women with a diagnosis of breast cancer.” Three years later, these women reported “greater negative psychosocial consequences compared with women who had normal findings in all 12 psychosocial outcomes.”
The study authors concluded that the false-positive findings had long-term implications on women’s psychological health.
The ACR and SBI questioned the methodology of the study, citing irregularities in the analysis, such as if the women with false-positive findings also had a family history of breast cancer, what further testing was done, and where the women completed the survey (at home or at the clinic).
“Anxiety regarding inconclusive test results is real and only natural,” the groups said in a release. “Physicians continue to refine the reporting process to ensure that patients receive results as quickly as possible. Attention to women’s feelings associated with test results is, and should be, a concern for those who provide this care.”
The organizations emphasized that the benefits of breast cancer screening outweigh potential harm.
AI-Initiated Recalls After Screening Mammography Demonstrate Higher PPV for Breast Cancer
March 18th 2025While recalls initiated by one of two reviewing radiologists after screening mammography were nearly 10 percent higher than recalls initiated by an AI software, the AI-initiated recalls had an 85 percent higher positive predictive value for breast cancer, according to a new study.
ECR Mammography Study: Pre-Op CEM Detects 34 Percent More Multifocal Masses than Mammography
February 28th 2025In addition to contrast-enhanced mammography (CEM) demonstrating over a 90 percent detection rate for multifocal masses, researchers found that no significant difference between histological measurements and CEM, according to study findings presented at the European Congress of Radiology.
Study: Mammography AI Leads to 29 Percent Increase in Breast Cancer Detection
February 5th 2025Use of the mammography AI software had a nearly equivalent false positive rate as unassisted radiologist interpretation and resulted in a 44 percent reduction in screen reading workload, according to findings from a randomized controlled trial involving over 105,000 women.